Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

Click for more information

4.39%

98.0¢ mesoblast limited

Trial for MIS-C? More news on secondary endpoints from Covid...

First 2 Last

Share
Profile

Follow
LearningEachDay

5,521 Posts.

2016

02/09/21

08:45

Post #: 55768724
Share

Originally posted by MJC73: ↑

I thought I'd create a new thread to discuss the potential near term catalysts for Mesoblast (and for fun throw in some speculation on the possibility that these will be positive)

Here's what I'm thinking off the top of my head

1. OTAT's signs off on the CMC and CQA process suitability (better than average due to advice from FDA on approach)

2. Confirmatory Covid trial gets green light and funding from Novartis (well they're still here so better than average)

3. Dr Perin publishes his article in NEJM with "amazing results" for CHF (near certainty as indicated by the Doc himself)

4. MSB gets clear indication of positive regulatory pathway for Rex-L for CLBP from FDA (50/50?)

5. Surgecenter comes forward to partner with MSB on a confirmatory trial for CLBP as per FDA guidance (speculative)

6. Crohn's disease study reports favorable outcomes for direct injection approach (better than average)

7. New Covid trial meets primary endpoint (given all the data they have had to analyse from the last trial - better than average)

8. Over 65's respond to new dosing in Covid trial (speculative)

Expand

Trial for MIS-C? More news on secondary endpoints from Covid Trial? Partnership for heart failure?

MSB Price at posting: $1.57 Sentiment: Buy Disclosure: Held
16 Upvote

0 Great analysis

Reply

Top Stories

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

STX

Strike Energy secures $153 million for Perth Basin gas projects

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

There are more pages in this discussion • 50 more messages in this thread...

First 2 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 98.0¢		Change -0.045(4.39%)		Mkt cap ! $1.164B

Open	High	Low	Value	Volume
$1.03	$1.04	97.0¢	$5.245M	5.221M

Buyers (Bids)

No.	Vol.	Price($)
12	21108	98.0¢

Sellers (Offers)

Price($)	Vol.	No.
98.5¢	32000	14

View Market Depth

No.	Vol.	Price($)
8	38515	0.980
15	75143	0.975
19	295031	0.970
17	143960	0.965
10	62850	0.960

Price($)	Vol.	No.
0.985	36181	15
0.990	98969	14
0.995	55473	9
1.000	69845	10
1.005	44404	5

Last trade - 12.32pm 24/06/2024 (20 minute delay)

MSB (ASX) Chart

SPONSORED BY